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ABSTRACT 
Thermoresponsive, stretchable, biodegradable and biocompatible polyester-based polyurethane 
(PEU) hydrogels, based on poly(glycerol sebacate) pre-polymer and poly(ethylene glycol)s of 
different molecular masses were synthesized by a facile solvent-based two-step method. The 
chemical and physical characteristics of the PEU hydrogels are tunable, enabling the design of 
various negatively thermosensitive, mechanically stable and biodegradable systems. The PEU 
hydrogels demonstrate reversible responses to a change in medium temperature from 5 oC to 37 
oC, with the swelling ratio at equilibrium varying from 499% to 12%. The hydrogels have a 
WHQVLOH<RXQJ¶VPRGXOXVXOWLPDWHWHQVLOHVWUHQJWKDQGHORQJDWLRQDWEUHDNLQWKHUDQJHRI-
0.20 MPa, 0.05-0.47 MPa and 426-623%, respectively, and show high stretchability and full 
shape recovery after compression. These are similar to the mechanical properties of adipose 
tissues. In vitro degradation tests show mass losses of 8.7-16.3% and 10.7-20.7% without and 
with the presence of lipase enzyme for 31 days, respectively. In vitro cell tests show clear 
evidence that some of the PEU hydrogels are suitable for culturing adipose-derived stem cells 
and dermal fibroblasts and hence for future soft tissue regeneration. The functionalities of the 
PEU hydrogels were also evaluated for potential applications in drug delivery, thermal actuation 
and ultralow power generation. The results demonstrate the versatility of these PEU hydrogels 
for a variety of biomedical and engineering applications. 
KEYWORDS 
Thermoresponsive hydrogel; biodegradation; biocompatibility; tissue engineering; drug delivery; 
actuation.  
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1. INTRODUCTION 
Stimuli-responsive hydrogels are of considerable interest for a range of applications, such as 
tissue engineering, drug delivery, actuation and sensing, due to their ability to respond to 
external chemical or physical stimuli.1 Hydrogels have attractive characteristics, owing to their 
high water content and three-dimensional (3D) network structure, which closely mimic the 
natural extracellular matrices of soft tissues.2 With respect to stimuli-responsive hydrogels, 
thermoresponsive hydrogels form the most common class, characterized with a temperature-
dependent deformation of their polymeric 3D network.3 Among these hydrogels, 
thermoresponsive poly(N-isopropylacrylamide) (PNIPAm) hydrogels have been extensively 
investigated, because of their well-defined stimulus sensitivity and transition temperature near 
the body temperature.1,3-5 However, the biomedical applications of PNIPAm and its copolymers 
are restricted due to their non-biodegradability, slow stimuli responsiveness and mechanical 
weakness.4,5 
Biodegradable and biocompatible polyurethane (PU)-based thermoresponsive hydrogels have 
recently received increasing attention.6,7 PUs offer attractive mechanical properties and have 
been studied in regenerative medicine applications.8 They are synthesized from a variety of 
polyols, diisocyanates, and chain extenders or crosslinkers, offering the flexibility of tailoring 
their properties to match specific requirements. The thermoresponsive properties of PU-based 
hydrogels are dependent on the balance of hydrophilic/hydrophobic groups and their interactions 
with water molecules via hydrogen bonding, in which the polymer chain network collapses or 
swells in response to the change in temperature of the aqueous medium.1,9 Poly(ethylene glycol) 
(PEG) is one of the most used polyols for designing PU-based hydrogels and it has been 
approved for use in medical applications by the U.S. Food and Drug Administration (FDA).10,11 
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PEG presents attractive physicochemical and biological properties, including hydrophilicity, 
solubility in water and polar organic solvents, non-toxicity and non-immunogenicity.2,12 Hence, 
the modulation of PU-based hydrogels with PEG improves the biocompatibility, and enables the 
adjustment of degradability and mechanical properties by varying the molecular mass or 
concentration of the PEG.7,13 
The ability to design PU-based hydrogels using a biodegradable and biocompatible polymer 
building block, either natural2,12,14 or synthetic,2,12,15,16 is an essential feature in tailoring their 
biodegradability and biocompatibility. Natural polymers are generally biocompatible, however 
their poor mechanical properties, fast degradation rates, poor reproducibility and potential 
immunogenicity restrict their use.2 In contrast, synthetic polymers have more predictable and 
reproducible physical and biological properties.2 Poly(glycerol sebacate) (PGS) is a synthetic 
biodegradable and biocompatible elastomer, specifically designed for soft tissue applications.17,18 
It is synthesized via a polycondensation reaction of glycerol and sebacic acid, forming a meltable 
and soluble pre-polymer (pre-PGS) which subsequently cures to create a covalently crosslinked 
PGS network.17,18 PGS can sustain and recover from deformations in mechanically dynamic 
environments, which is attributed to its 3D molecular structure and elastomeric nature.19 PGS is 
bioresorbable and both of its monomers haven been approved by the FDA for the utilization in 
medical applications.17 Previous in vitro and in vivo studies have demonstrated good cell 
compatibility with minimal inflammatory response to PGS implants,17,20-22 as well as relatively 
linear degradation kinetics and good retention of mechanical strength during degradation due to 
its surface erosion patterns.17,20-22 While PGS itself exhibits tunable properties,18 the functional 
hydroxyl groups of PGS also allow one to incorporate different functionalities by reacting with 
the hydroxyls and hence tailoring its physiochemical properties, as shown by recently developed 
PGS-based copolymers, blends and composites.18,23-26 For instance, hydrophilic segments such as 
 5 
citric acid or PEG were successfully incorporated into the PGS backbone, resulting in PGS-based 
copolymers with improved and tunable hydrophilic properties,24,26,27 and the use of isocyanate-
based crosslinkers allowed researchers to design mechanically highly tunable PU-based 
elastomers under mild reaction conditions.23 However, most of these studies aimed to either 
improve the processability of PGS, or modify the mechanical properties, degradation behaviour 
or hydration properties of PGS.18 While pristine PGS has been recently investigated for basic 
one-way shape-memory effects,28 the development of reversibly stimuli-responsive PGS-related 
hydrogels has not been reported. 
In this work, we report novel thermoresponsive, stretchable and biodegradable polyester-
based polyurethane (PEU) hydrogels, synthesized from pre-PGS and PEGs of different 
molecular masses (MWts), both containing hydroxyl groups, with aliphatic hexamethylene 
diisocyanate (HDI). HDI was selected due to its extensive use in synthesizing biocompatible 
polyurethanes.23,29 We hypothesized that the synthesis of the PEU using (I) biodegradable pre-
PGS as the main macromolecular crosslinker, (II) hydrophilic PEG as the main polyol 
component, and (III) hydrophobic HDI as the diisocyanate component, could create a chemically 
crosslinked thermoresponsive hydrogel with the combined advantages of PGS, PEG and PU. By 
varying the MWt of PEG, the chemical and physical characteristics of the PEU hydrogels could 
be tailored. The structure and properties of these thermoresponsive materials were investigated, 
and their potential applications for tissue engineering, drug delivery and thermal actuation were 
evaluated. The structure of the PEUs was characterized by spectroscopic and calorimetric 
measurements, the mechanical properties were analyzed via quasi-static and cyclic tensile and 
compression tests, and the hydration kinetics and swelling behavior were studied under various 
medium temperatures. In vitro degradation tests were carried out in media with and without 
lipase, and cell proliferation response was examined in vitro with human adipose-derived stem 
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cells (ADSCs) and dermal fibroblasts (FIBs). Drug encapsulation and release as well as 
temperature-induced actuation behaviour were studied. The potential of fabricating the PEU 
material into different forms such as microspheres and large 3D porous scaffolds was also 
demonstrated. 
2. MATERIALS AND METHODS 
2.1 Materials 
Sebacic acid, glycerol, HDI, Tin (II) 2-ethylhexanoate (Tin (II)), PEG (with the number average 
molar mass (ܯഥ௡) of 400 g mol-1 (PEG-400), 950-1050 g mol-1 (PEG-1000) and 1305-1595 g 
mol-1 (PEG-1450)), dimethylformamide, 1,4-dioxane, acetone, diemethyl carbonate, toluene, 
tetrahydrofuran (THF), chloroform, ethanol, hexane, mineral oil, Span 80, n-heptane, lidocaine, 
phosphate buffered saline (PBS) tablets (for preparing a PBS-water solution of pH 7.4), lipase 
from porcine pancreas (54 U mg-1), 'XOEHFFR¶V PRGLILHG (DJOH¶V PHGLXP '0(0 WU\SVLQ-
ethylenediaminetetraacetic acid (Trypsin/EDTA), formaldehyde, phalloidin-fluorescein 
isothiocyanate (phalloidin-FITC) and resazurin were purchased from Sigma-Aldrich. Fetal calf 
serum (FCS), penicillin-streptomycin, glutamine and amphotericin B were purchased from 
Gibco. Collagenase type A was acquired from Roche Diagnostics GmbH. Difco-trypsin plus was 
obtained from Difco Laboratories. 
2.2 Synthesis and Characterization of PGS Pre-polymer 
Pre-PGS was synthesized according to published methods,17,30 by reacting a 1:1 molar mixture of 
sebacic acid and glycerol at 120 °C for 72 h under a low flow of nitrogen gas and at constant 
stirring. The ܯഥ௡, the mass average molar mass (ܯഥ௪) and the polydispersity index (PDI) of pre-
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PGS were measured by gel permeation chromatography (GPC) using an Erma ERC-7512 
Refractive Index detector and calibrated with polystyrene standard samples. 
2.3 Solvent-based Synthesis of PEUs 
PEUs were synthesized by using a solvent-based two-step approach with a fixed molar ratio 
(glycerol : isocyanate (NCO)-terminated PEG = 1 : 0.30). Briefly, the first step involved the 
reaction of PEG (1 mmol; PEG-400, PEG-1000 or PEG-1450) and HDI (2 mmol) in 1,4-dioxane 
(20 mL) with Tin (II) (0.05% w/v) as the catalyst for 1 h at 85 °C. In the second step the NCO-
terminated PEG/1,4-dioxane solution was cooled down to 55 °C, to which a pre-PGS solution 
(3.4 mmol pre-PGS in 20 mL 1,4-dioxane with 0.05% w/v Tin (II)) was added and reacted for 5 
h. At each step the reaction flasks were purged with nitrogen and sealed. The reacted solution 
was poured onto a non-sticky mould and the solvent was allowed to evaporate for 2 days at room 
temperature and another 2 days in a vacuum oven at 40 °C, which also allowed for further 
crosslinking. All the specimens were subjected to a cleaning procedure (24 h ethanol saturation 
and drying in a vacuum oven at 37 °C) prior to tests to remove unreacted pre-polymer and 
monomers. The nomenclature of the synthesized hydrogels is presented as PEU-;ZKHUH³;´
represents ܯഥ௡ of the utilized PEG: PEU-400, PEU-1000 and PEU-1450. 
2.4 Characterization of PEUs 
Proton nuclear magnetic resonance spectroscopy (1H NMR) was performed on a Bruker Avance 
III HD 500, and samples were recorded at 25 °C at 500 MHz, using deuterated chloroform 
(CDCl3) as the solvent. PEUs were soaked overnight in CDCl3 and the acquired 
1H NMR data 
were analyzed using ACDLABS/1D NMR software. Attenuated total reflectance Fourier 
Transform Infrared Spectroscopy (ATR-FTIR) was performed on a Perkin Elmer Spectrum One 
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NTS analyzer, operated in the mid-infrared region of 4000-450 cm-1 and recorded with a 
resolution of 1 cm-1. Raman spectroscopy was executed on a Renishaw inVia Raman 
spectroscope using a 514.5 nm wavelength laser. Spectra were recorded between 500-3500 cm-1 
with a laser power of 2 mW and a spectral resolution of 0.5 cm-1. Differential Scanning 
Calorimetry (DSC) was carried out on a Perkin Elmer Diamond DSC, and temperature scans 
from -60 °C to 120 °C at 10 °C min-1 under a nitrogen flow rate of 20 ml min-1 were performed 
during two consecutive heating cycles. The heat capacity change in the second heating cycle was 
used for analysis. 
The solubility of PEU film specimens was evaluated by immersing the specimens in a solvent, 
1.4-dioxane, dimethylformamide, diemethyl carbonate, toluene, chloroform, acetone or ethanol, 
for 24 h at 21 °C. The sol contents of non-cleaned PEU film specimens (n = 5) were calculated 
by determining the mass difference after 24 h ethanol saturation at 21 °C. 
Quasi-static tensile and compression tests were performed on dry and hydrated PEU film 
specimens (hydrated PEU specimens (donated as hydrogels herein) had been immersed in PBS 
solution for 24 h at 37 °C and were immediately removed from the solution for the tests), while 
cyclic tensile and compression tests were conducted on PEU hydrogels. Briefly, quasi-static 
uniaxial tensile tests were carried-out with a 10 N load cell on a Hounsfield H100KS mechanical 
testing machine (Tinius Olsen, USA), at a tensile strain rate of 50 mm min-1 till fracture (ASTM 
' ZLWK ³GRJ ERQH´ VKDSHG VSHFLPHQV Q    ZLGWK  PP JDXJH OHQJWK 20 mm, 
thickness: 0.42-1.29 mm). Cyclic tensile tests (n = 3; width: 2.6 mm, gauge length: 20 mm, 
thickness: 0.82-1.65 mm) were performed under the same testing set-up at a tensile strain rate of 
50 mm min-1 and stretched to 50% strain during 20 cycles. Quasi-static uniaxial compression 
tests were executed on cylindrical specimens (n = 7; diameter: 6 mm; thickness: 1.10-3.72 mm) 
with a 1 kN load cell up to a strain of 75% and a strain rate of 1 mm min-1. Cyclic compression 
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tests (n = 3; diameter: 6 mm; thickness: 1.09-3.57 mm) were performed under the same testing 
set-up at a strain rate of 1 mm min-1 and compressed to 50% strain during 20 cycles. All the tests 
were performed at ambient conditions (21 °C). 
Hydration kinetics and swelling behaviour of dried PEU film specimens (n = 5) were 
analyzed at various medium temperatures for up to 48 h. Dry specimens of initial known mass 
were immersed in PBS solution at constant 5 °C, 21 °C or 37 °C, which represent three important 
temperature conditions of possible storage or application environments (e.g. fridge (5 °C), room 
temperature (21 °C) and human body temperature (37 °C)). At specific time intervals, swollen 
specimens were taken out of the medium, with excessive surface water removed and their 
swollen mass determined, and the tests was continued until the specimens reached the stage of 
equilibrium. The mass swelling ratio was determined by the difference between the masses of the 
swollen sample and the initial dry sample divided by the mass of the initial sample. The 
reversible swelling/deswelling behavior of dried PEU film specimens (n = 5) was analyzed in 
PBS solution at alternating temperatures of 5 °C and 50 °C, at an interval of 40 min for up to 4 h. 
In vitro degradation studies were performed on PEU film specimens (n = 3; thickness: 0.57 ± 
0.10 mm; width: 2.5 ± 0.03 mm; length: 4.8 ± 0.02 mm), based on our previous work.31,32 
Briefly, tests were performed in a shaker incubator (Stuart SI500; 100 rpm) at 37 °C in two 
separate degradation media: a lipase-containing PBS solution (110 U L-1; serum lipase in healthy 
adults is in the range of 30-190 U L-1)33 and an enzyme-free PBS solution as control. Both 
degradation media were changed every day to maintain enzymatic activity. The specimens were 
removed from the degradation medium after 1, 3, 7, 11, 15, 19, 23, 27 and 31 days of incubation, 
washed with distilled water, dried in a vacuum oven at 37 °C, and weighed. Scanning electron 
microscopy (Camscan S2; SEM) was performed on the specimens after 31 GD\V¶ in vitro 
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degradation, as well as on untreated samples, at 5 kV. The specimens were gold coated for 3 min 
at 15 mA by using a sputter coater (Emscope SC500). 
2.5 Drug Encapsulation and Release Tests of PEUs 
For the drug encapsulation, dry punched-out PEU film specimens (n = 5; diameter: 6 mm; 
thickness: 0.74 ± 0.18 mm) were soaked in a lidocaine solution (0.01 g mL-1 PBS, 10 mL) for 48 
h at 5 °C. The swollen specimens were removed and dried in a vacuum oven for 24 h at 37 °C. 
The lidocaine-loaded samples were then immersed in PBS (10 mL) in a shaker incubator (100 
rpm) at 37 °C. At several time intervals, 1 mL was removed and replaced by the same volume of 
fresh PBS. The cumulative drug release rate was calculated by evaluating the characteristic 
absorbance peak of lidocaine at 263 nm against a calibration curve of lidocaine-containing PBS 
solutions at known concentrations. 
2.7 In Vitro Cell Culture Experiments 
Skin and associated fat were obtained with informed consent from patients undergoing elective 
surgery for breast reductions or abdominoplasties, from tissue not required for their treatment 
donated for research. All donated tissues were handled on an anonymous basis, under a Human 
Tissue Authority research tissue bank license (number 08/H1308/39). Human subcutaneous fat 
from discarded skin was selected as the ADSC source. Mechanical and enzymatic (collagenase 
type A) digestion was followed by several washes, and the stromal vascular fraction was cultured 
in DMEM (supplemented with 10% FCS, 100 IU ml-1 penicillin-streptomycin, 100 µg ml-1 
glutamine and 0.625 µg ml-1 amphotericin B). The human ADSCs were subcultured to passage 4 
for use in the experiments. Human skin biopsies were treated enzymatically (Difco-trypsin plus) 
to separate the dermis. FIBs were obtained after collagenase treatment (collagenase type A) from 
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finely minced dermis and cultured in supplemented DMEM. The human skin FIBs were 
subcultured to passage 9, as described previously.34 
Experiments were performed in triplicate. Briefly, PEU specimens (diameter: 15 mm) were 
placed in a 12-well plate and sterilized with 0.1% peracetic acid in PBS overnight. Then, 
specimens were washed 3 times with PBS (1 h each) and dried overnight in a sterile laminar flow 
culture hood under UV light. The sterilized and dried specimens were soaked in DMEM 
overnight in an incubator (37 ºC, 5% CO2), and fixed with a metal ring (internal diameter: 10 
mm) for cell seeding. After cell trypsinisation with Trypsin-EDTA, ADSCs (5 x 104 cells per 
sample) and FIBs (5 x 104 cells per sample) were seeded onto the PEU specimens with DMEM 
(cell-free specimens were included as controls in DMEM). After 2 h incubation (37 ºC, 5% 
CO2), rings and DMEM were removed and a metabolic activity assay was performed (1 ml of 
resazurin (5 µg mL-1 in PBS) was added to each well and incubated for 60 min). The absorbance 
at 570 nm was measured in a colorimetric plate reader (Bio-TEK). Resazurin was then removed 
and samples returned to culture conditions with 2 mL of DMEM. This metabolic assay was 
repeated on days 3, 6 and 9 and images of the well plates were taken after each incubation. After 
the final incubation, all samples were washed in PBS and fixed with 3.7% formaldehyde in PBS 
for 15 min. After 3 PBS washes, the samples were incubated in 2 mL phalloidin-FITC (diluted 
1:500 in PBS) for 30 min. After 3 further PBS washes, images (512x512 pixels) were obtained 
using a Zeiss LSM 510Meta inverted confocal microscope and W N-Achroplan 40x 0.75 NA 
objective, with a 12.8 µs pixel dwell time. FITC was excited using a 488 nm laser and emission 
detected between 500 and 550 nm. 
2.8 Water Temperature Activated Force Generation Measurements 
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Water temperature activated force generation was evaluated on PBS saturated (at 21 °C for 48 h) 
and stretched (constant strain = 40 %) PEU-1450 strip samples (n = 2; thickness: ~1.45 mm; 
width: 8 mm; gauge length: 20 mm) (See Figure S1A for the test set-up). During the testing 
period water temperature was alternated between 21 °C and 37 °C, or 5 °C and 37 °C, with an 
interval of 10 min for up to 70 min. This was accomplished by exchanging the same volume of 
water (of the desired temperature) rapidly. The force was measured with a 10 N load cell on a 
Hounsfield H100KS mechanical testing machine. 
2.9 Water Temperature Responsive Cantilever Tests 
A two-layer cantilever was constructed from a pre-hydrated PEU-1450 (24 h PBS saturation at 
21 °C; thickness: ~2.1 mm; width: 5 mm; gauge length: 50 mm) and a flexible 
poly(tetrafluoroethylene) (PTFE) film strip (Figure S1B). The two strips were connected to each 
other at both ends only using an adhesive. The PTFE side was further fixed with adhesive to the 
centre of a screw tip, allowing both strip ends to move freely. The test was performed according 
to the following steps. The cantilever was first placed in cold PBS (5 °C) for 15 min (low 
medium temperature = PEU hydrogel swelling). The test started by adding hot PBS (95 °C), until 
the medium exchange resulted in a stable high temperature of ~90 °C (high medium temperature 
= PEU hydrogel deswelling). After 3 min cold PBS (5 °C) was added until a low temperature of 
~5 °C was reached. The test was completed within 6 min. 
2.10 Statistics 
All measurements were reported as mean ± standard deviation (SD) with a confidence level of 
95%. Differences were statistically tested against a null hypothesis of no difference between 
samples using a two-sample t-test (two-tailed) with equal variance not assumed. Two-way 
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analysis of variance (ANOVA) was used to determine the differences in metabolic activity of the 
in vitro cultured ADSCs and FIBs in respect to test time and material. A p value < 0.05 was 
considered to be statically significant. 
3. RESULTS AND DISCUSSION 
3.1 Synthesis and Characterization of PEUs 
 
Figure 1. (A) Synthesis scheme of PEUs. (B) Sketch showing the formation of the PEU network. 
Chemically crosslinked PEU hydrogels were synthesized using a solvent-based two-step 
approach with a fixed molar ratio (glycerol : NCO-terminated PEG = 1 : 0.30) (Figure 1A-B). 
The first step involved the synthesis of NCO-terminated PEGs, by reacting PEG (ܯഥ௡ = 400, 
1000 or 1450) with HDI in 1.4-dioxane. In the second step, pre-synthesized pre-PGS was 
dissolved in 1.4-dioxane and added to the NCO-terminated PEG solution to produce PEU 
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through the crosslinking reaction between the hydroxyl groups of the pre-PGS units and the ±
NCO groups from the functionalized PEG. The pre-PGS in use had a ܯഥ௡, ܯഥ௪ and PDI of 1549 g 
mol-1, 10522 g mol-1 and 6.8 respectively, as determined by GPC. 
 
Figure 2. Normalized 1H NMR spectra of (A) PEU-400, (B) PEU-1000 and (B) PEU-1450. The 
figures on the right show the methylene proton related peak of PEG, ³k´, increases with its 
increasing molecular mass. 
The molecular structure of the PEUs synthesized using three different molecular masses of 
PEG was confirmed by 1H NMR spectroscopy (Figure 2), characterized with distinctive peaks of 
pre-PGS and PEGs (Figure S2), as well as urethane related peaks due to the reaction between 
pre-PGS and the NCO-terminated PEGs. Characteristic peaks of pre-PGS related methylene 
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protons were assigned at 1.29, 1.61 and 2.32 ppm (position ³H´, ³G´DQG³F´) for sebacic acid, 
while peaks from 4.05-4.35 ppm and 4.92-SSPSRVLWLRQ³E´DQG³D´ZHUH OLQNHG WR WKH
methylene protons of glycerol.27,35 The methylene proton related peaks of PEG were assigned at 
 SSP SRVLWLRQ ³N´ DQG - SSP SRVLWLRQ ³M´ ZKLFK RYHUODSV SRVLWLRQ ³E´27 The 
LQWHQVLW\RISHDN³N´ LQFUHDVHGZLWK HQKDQFHG 0:WRI3(* )LJXUH5LJKW FRQILUPLQJ WKH
presence of a higher mass of PEG segments within the PEU. The peaks at 1.48 ppm, 1.61 ppm, 
 SSP DQG  SSP SRVLWLRQ ³L´ ³K´ ³J´ DQG ³I´) were assigned to urethane and HDI 
related methylene protons, highlighting urethane bonds. Compared to the glycerol related peaks 
in the 1H NMR spectra of pre-PGS (Figure S2), the 1H NMR data of PEUs presented increased 
integral signals at 4.92-5.24 ppm (SRVLWLRQ ³D´, indicating that the urethane-bond formation 
between the NCO-terminated PEGs and the free hydroxyl groups of pre-PGS occurred 
preferentially with the hydroxyl groups of glycerol.35 
The analysis of ATR-FTIR spectra of PEUs (Figure 3A), pre-PGS and PEGs (Figure S3) 
supported the 1H NMR results. The spectra of PEUs showed the stretching vibrations of N-H at 
3360 cm-1, C=O at 1723 cm-1, amide III at 1241 cm-1, C-O at 1093 cm-1, C-O-C at 948 cm-1, and 
amide IV at 842 cm-1, as well as the bending vibrations of amide II at 1532 cm-1, confirming the 
formation of urethane linkages.7,17,36 In contrast, ATR-FTIR spectra of NCO-terminated PEGs 
(Figure S3) were characterized with the stretching vibration of HDI related ±NCO end groups at 
2270 cm-1, the stretching and bending vibrations of urethane-bond linked C=O and amide II at 
1723 cm-1 and 1537 cm-1, and the stretching vibration of PEG associated C-O-C at 950 cm-1, 
showing the unreacted residual ±NCO groups at the chain ends and the urethane-bond formation 
between HDI and PEG.7,36 The absence of ±NCO band at 2270 cm-1 in all the three spectra of the 
PEUs indicates the complete reaction of the ±NCO end groups from the PEG with the hydroxyls 
of pre-PGS. 
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Figure 3. (A) ATR-FTIR spectra, (B) Raman spectra, and (C) DSC curves of PEUs. The 
spectra/curves were shifted vertically for clarity. 
Raman spectra analysis of PEUs (Figure 3B) also affirmed the above 1H NMR and ATR-
FTIR results. The spectra of PEUs showed the stretching vibrations of CH2 in the range of 2700-
3000 cm-1, C=O at ~1731 cm-1, the bending vibrations of CH2 and CH2-CH2 in the range of 
1200-1500 cm-1, the stretching vibration of C-O at ~1140 cm-1 and the rocking vibration of CH2 
at 843 cm-1.37-39 Comparing the spectra of the PEUs with pre-PGS and PEGs (Figure S4) showed 
a decrease of the pre-PGS related stretching vibration of C-O at 1102 cm-1, as well as the 
disappearance of the PEG linked twisting vibration peaks of C-O-H at ~533 cm-1 and ~581 cm-1, 
which are associated to the hydrogen bond reduction due to the formation of urethane bonds.37-39 
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No peaks for unreacted -NCO urethane groups were detected in the spectra of PEUs, confirming 
the establishment of urethane linkage. 
The thermal properties of the PEUs and their main individual components were analyzed by 
DSC (Figure 3C and S5). PEUs presented glass transition temperature ( ௚ܶ) values below 0 °C, 
which decreased with the incorporation of longer PEG chains due to higher chain mobility (PEU-
400: ௚ܶ = -27.7 °C; PEU-1000: ௚ܶ = -40.3 °C; PEU-1450: ௚ܶ = -45.2 °C). No crystallization 
temperature ( ௖ܶ) or melting temperature ( ௠ܶ) was detected for PEU-400 and PEU-1000 
specimens within the test range, owing to the lower-molecular-mass PEG segments, which yield 
restricted chain mobility and no crystallization in the PEU network.40 However, ௖ܶ and ௠ܶ were 
observed in PEU-1450 specimens ( ௖ܶ = -12.9 °C; ௠ܶ = 29.1 °C), owing to the presence of the 
semi-crystalline PEG-1450 in the network.7 Pre-PGS presented three ௠ܶ peaks at -7.6 °C, 14.4 
°C and 33.4 °C, which is typical for pre-PGS in its partially crosslinked state and depends on its 
synthesis procedure.20,41 PEG-400 exhibits a low ௠ܶ of 2.1 °C, while PEG-1000 and PEG-1450 
presented higher ௠ܶ values of 39.9 °C and 50.8 °C (Figure S5), respectively. The ௠ܶ observed 
for the PEU-1450 specimen was lower than that from neat PEG-1450, indicating that the 
chemically crosslinked network and the reduced chain mobility affected the crystallization of the 
PEG-1450 segments.42 Overall, the results reveal that the MWt of PEG affects the thermal 
transition of the PEU. 
All the PEUs were insoluble in various organic solvents (1,4-dioxane, dimethylformamide, 
diemethyl carbonate, toluene, chloroform, acetone and ethanol) and only showed strong swelling 
after immersion for 24 h, confirming the formation of a covalently crosslinked network. Residual 
analysis of PEU-400, PEU-1000 and PEU-1450 specimens gave mass losses of 23.6 ± 2.4%, 
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24.7 ± 0.5% and 24.5 ± 7.7% respectively, after 24 h ethanol extraction, indicating the existence 
of non-crosslinked components. 
3.2 Mechanical Properties of PEUs 
Table 1. Tensile and compression properties of PEUs. 
 
  Tensile  Compression 
 
Sample 
code  
<RXQJ¶V 
 modulus, Et / 
MPa 
Ultimate 
tensile 
strength, ıtmax 
/ MPa 
Elongation 
at break, İtb / 
% 
Energy at 
 break, T / 
MJ m-3 
 
<RXQJ¶V 
modulus, Ec / 
MPa 
Comp. stress 
 at İc75%, ıc75% 
/ MPa 
D
ry
 
PEU-400  0.72 ± 0.01 0.70 ± 0.02 438 ± 7 1.63 ± 0.07  1.86 ± 0.81 12.68 ± 1.01 
PEU-1000  0.71 ± 0.14 0.49 ± 0.04 400 ± 67 1.03 ± 0.17  0.80 ± 0.07 9.36 ± 2.55 
PEU-1450  13.11 ± 2.22 1.59 ± 0.25 505 ± 77 6.78 ± 0.93  17.91 ± 0.77 16.36 ± 2.86 
H
yd
ra
te
d 
PEU-400  0.20 ± 0.11 0.47 ± 0.11 426 ± 44 1.09 ± 0.10  1.44 ± 0.22 10.39 ± 1.37 
PEU-1000  0.03 ± 0.01 0.05 ± 0.01 497 ± 153 0.19 ± 0.03  0.44 ± 0.17 4.60 ± 0.86 
PEU-1450  0.02 ± 0.01 0.07 ± 0.01 623 ± 193 0.23 ± 0.04  0.10 ± 0.02 0.67 ± 0.07 
 
The mechanical properties of PEUs were determined under dry and hydrated states by quasi-
static tensile and unconfined compression tests, while cyclic tensile and compressive testing 
were also performed for hydrated PEU hydrogels (Figure 4 and S6, Table 1). The quasi-static 
mechanical properties of dry PEU-400 and PEU-1000 were similar under tensile load, while dry 
PEU-VKRZVVLJQLILFDQWO\KLJKHUPHFKDQLFDOSURSHUWLHVZLWKWKHWHQVLOH<RXQJ¶VPRGXOXV
tensile strength, elongation at break of 13.11 MPa, 1.59 MPa and 505%, respectively (Figure 
4A). Correspondingly, dry PEU-400 and PEU-1000 were comparatively flexible, whereas the 
PEU-1450 specimens were more rigid. Moreover, dry PEUs demonstrated significant differences 
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LQFRPSUHVVLYH<RXQJ¶VPRGXOXVDQGcompressive stress at 75% strain, with the dry PEU-1450 
specimens again showing the highest stiffness (Figure 4B). This can be accounted for by the 
presence of the semi-crystalline PEG-1450 with the highest molecular mass in the PEU network, 
as previously confirmed by DSC results. 
With respect to the mechanical properties of hydrated PEU hydrogels, complex deformations 
such as knotting and stretching could be performed on all the PEU hydrogels without fracture 
(Figure 4C), demonstrating excellent flexibility and stretchability. One of the main issues with 
most hydrogels is their mechanical weakness.4,5 Ideally, hydrogels for soft tissue engineering 
should be structurally stable and flexible to withstand mechanical forces and deformations in 
demanding in vivo environments.4,5 Tensile test results of PEU hydrogels indicated that an 
increase in PEG MWt from 400 to either 1000 or 1450 led to a decrease with statistical 
significance (p   LQ WKH WHQVLOH <RXQJ¶V PRGXOXV DQG WHQVLOH VWUHQJWK DV ZHOO DV D
significant increase in the tensile energy at break of the PEU hydrogel. PEU-1450 hydrogels 
SUHVHQWHG WKH ORZHVW <RXQJ¶V PRGXOXV RI  03D D WHQVLOH VWUHQJWK RI  03D DQG WKH
highest elongation at break of 623% (Figure 4D). Furthermore, all the PEU hydrogels could be 
compressed to a high strain (75%) without fracture and recover their original shape upon the 
release of the load (Figure 4E and S6). The PEU hydrogels presented significant differences in 
FRPSUHVVLYH<RXQJ¶VPRGXOXV DQGFompressive stress at 75% strain. The PEU-1450 hydrogel 
demonstrated the softest characteristics overall. 
The effective crosslink density (݊௘௙௙) of the PEU hydrogels was calculated from compressive 
testing results (based on 24 h saturation in PBS at 37 °C) by Equation 1 and S1-3,43,44 
ߪ௖ ൌ ݊௘௙௙ܴܶ߶ଶଵȀଷ߶଴ଶȀଷሺߙ െ ߙିଶሻ               (1) 
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where ߪ௖ is the applied force of per unit area of swollen hydrogel during compression, ܴ is the 
gas constant, ܶ is absolute temperature, ߶ଶ is the polymer volume fraction in the swollen state, ߶଴ is the polymer volume fraction in the gel in the relaxed state, and ߙ is the deformation ratio 
(ߙ ൌ ܮȀܮ଴ ൒ ͲǤͻͷ) under compression. The values of ݊௘௙௙ were calculated as 322, 64 and 11 
mol m-3 for PEU-400, PEU-1000 and PEU-1450 hydrogels, respectively. The decrease of the 
tensile strength and <RXQJ¶VPRGXOXV, as well as the increase of elongation at break in the PEUs 
with higher MWts is a consequence of the increase in the chain length between the neighbouring 
crosslinks, lowering the ݊௘௙௙ in the hydrogels and improving their flexibility, which correlates 
with the swelling properties of the hydrogels2 discussed in Section 3.3. 
 
Figure 4. Representative quasi-static (A) tensile and (B) compression stress-strain (test 
terminated at a compressive strain of 75%) curves of dry PEUs. (C) Mechanical knotting and 
stretching reliability of PEU-1450 hydrogel specimens. Representative quasi-static (D) tensile 
and (E) compression stress-strain curve of PEU hydrogels. Representative cyclic (F) tensile and 
(G) compression stress-strain curves of PEU hydrogels. 
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Cyclic stress-strain curves of PEUs were characterized with a hysteresis loop during tensile 
and compression tests (Figure 4F-G). The hysteresis, or dissipated energy (݁ௗ), was determined 
by evaluating the area between the loading and unloading curves during cyclic tensile or 
compression tests, and a hysteresis loss ratio (݄௥) was defined by Equation 2,45 
݄௥ ൌ ௘బି௘ೝ௘బ ൌ ௘೏௘బ                (2) 
where ݁଴ and ݁௥ are the input and retraction strain-energy densities, respectively. Under cyclic 
tensile testing, minimal ݄௥ was observed for all the PEU hydrogels. The PEU-400, PEU-1000 
and PEU-1450 hydrogels were characterized with ݄௥ values of 0.06, 0.11 and 0.15 after 20 
cycles of tensile loading to 50% strain, respectively. In respect to cyclic compression testing, 
PEU-1450 specimens showed a ݄௥ of 0.31, while the PEU-400 and PEU-1000 specimens 
presented higher degrees of ݄௥ of 0.74 and 0.55 after 20 cycles of compression loading to 50% 
strain (Figure 4G), respectively. The expelling of water from the hydrogel observed during the 
loading cycles presumably contributed to the higher hysteresis loss under compression. 
Overall, the PEU hydrogels reported here show excellent performance under quasi-static and 
cyclic tensile and compressive loads. They are structurally stable, highly stretchable and suitable 
to engineer scaffolds for a range of soft tissues, such as human cardiac muscles <RXQJ¶V
modulus: 0.01-0.30 MPa)46 or high stress adapted adipose tissue <RXQJ¶VPRGXOXV0.02-0.18 
MPa)47 due to their similar mechanical properties. The incorporation of PEG segments with 
different MWts into the PEU hydrogel altered mechanical properties. The PEG segment with a 
higher MWt improved the flexibility and stretchability of the PEU hydrogel, while reducing their 
strength and modulus, mainly due to its lower crosslink density and higher water uptake (see 
below). 
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3.3 Swelling Properties of PEUs 
The hydration behaviour of the PEUs was evaluated in PBS at 5, 21 and 37 °C (Figure 5A-E). 
The mass swelling ratio of the PEUs increased rapidly within the first 12 h, and gradually 
reached a plateau after 24 h (Figure 5B-D). At 5 °C, PEU-400, PEU-1000 and PEU-1450 
presented the highest ratios of swelling at equilibrium of 31%, 207% and 499%, respectively, 
among the three test temperatures. PEU-400, PEU-1000 and PEU-1450 reached swelling ratios 
at equilibrium of 20%, 154% and 426% at 21 °C, and of 12%, 113% and 235% at 37 °C, 
respectively. The difference in the swelling ratio of the PEU hydrogels between low and high test 
temperatures is statistically significant (p < 0.05). The PEUs presented negative thermo-
sensitivity, and the equilibrium ratio of swelling depended on the medium temperature as well as 
the hydrophilic/hydrophobic segment composition of the PEUs. The swelling capacities of the 
PEUs increased with higher MWt PEGs, due to the increased chain length between the crosslinks 
as discussed previously and the increased hydrophilicity of the PEGs.7 Analysis of the dynamic 
swelling/deswelling behavior of the PEU hydrogels demonstrated repeatable and reversible 
response to alternating medium temperatures (Figure 5F). At lower medium temperatures the 
hydrogen bonding between hydrophilic PEU polymer segments and the water molecules are 
dominating, while at higher medium temperatures the hydrophobic interactions between the PEU 
polymer segments are enhanced (due to the increased intrinsic affinity of the polymer chains), 
causing the secretion of hydrated water molecules from the PEU network.1,9 The PEUs presented 
relatively high swelling rates, while the deswelling rates were slightly lower, which can be in 
part associated with the alternation of the matrix permeability during the change of the medium 
temperature.48 The swelling/deswelling rates depend on the specific surface area of the specimen, 
the composition of the hydrogel and the environmental conditions. These results also indicated 
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that the PEUs with higher MWt PEGs would respond with greater swelling/deswelling rates 
upon minor changes of temperature, thus making these PEU hydrogels more attractive for 
potential thermosensitive actuation applications. 
 
Figure 5. (A) Equilibrium ratio of swelling of PEU specimens in PBS solution as a function of 
the temperature. (B) Hydration kinetics of PEU samples at 5 °C, (C) 21 °C and (D) 37 °C for 2 
days. (E) Pictures of PEU specimens after 24 h hydration at 5 °C, 21 °C and 37 °C. (F) Dynamic 
swelling/deswelling behaviour of PEU specimens at 5 °C and 50 °C at an interval of 40 min. 
3.4 In Vitro Degradation 
The biodegradability of thermoresponsive hydrogels is an important factor for potential 
biomedical applications.3,7 In vitro degradation studies were performed in PBS with or without 
lipase for up to 31 days at 37 °C in a shaker bioincubator (Figure 6 and S7). The results illustrate 
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that the rate of degradation of the PEUs can be tuned, depending on the MWt of the PEG 
segments. The higher MWt PEGs showed faster degradation over the 31 days studied and this 
was only slightly enhanced in the presence of the enzyme (which catalyses the hydrolysis of the 
ester bonds of the PGS segments).31,32 The PEUs showed bulk degradation, attributable to their 
high water content, in which an increase in the PEG MWt, as well as the presence of lipase led 
overall to a greater mass loss. PEU-400 underwent similar mass losses of 10.1% and 10.7% in 31 
days in the enzyme-free and lipase-containing PBS solution, respectively. PEU-1000 and PEU-
1450 underwent mass losses of 8.4% and 16.3% in 31 days in the enzyme-free PBS solution, 
which increased to 12.9% and 20.7%, respectively, with statistical significance, in the lipase-
containing solution. 
 
Figure 6. Percentage of mass loss of PEU specimens incubated in PBS solutions with or without 
lipase in a shaker incubator for up to 31 days at 37 °C. 
Together with the matched mechanical properties discussed above, biodegradability enables 
the potential application of the PEUs in soft tissue engineering.1,3-5 The use of PNIPAm-based 
hydrogels and its copolymers in biomedical applications are restricted, due to non-
biodegradability and toxicity of PNIPAm in its monomeric form.4,5,49 In comparison to recently 
developed PGS-co-PEG block copolymers,24,27 the PEU hydrogels presented slower degradation 
kinetics owing to the urethane linkages in the covalently crosslinked network. For instance, 
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enzyme-free in vitro degradation tests of the PGS-co-PEG block copolymers gave ~15-80% 
mass losses in 21 days.24 According to prior studies,27,50 the use of higher MWt PEGs in in vivo 
applications is preferred within the test range (< 40,000 or 60,000 g mol-1) which showed that 
high levels of low MWt PEGs JPRO-1) led to adverse renal effects in human and animal 
experiments. 
3.5 In Vitro Cell Viability and Proliferation 
 
Figure 7. Metabolic activity assay results of ADSCs cultured on (A) PEU-400, (B) PEU-1000 
and (C) PEU-1450 after subtracting the data for cell-free PEU controls. The data are represented 
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as mean ± SD (n = 3; כ = p < 0.05, two-sample t-test). The images on the right are representative 
confocal fluorescence micrographs following 9 days in vitro cultivation. 
Metabolic activity assay with resazurin was used to evaluate the in vitro cell viability and 
proliferation of ADSCs (Figure 7A-C) and FIBs (Figure S8) on PEU hydrogels for up to 9 days, 
while confocal fluorescence microscopy was performed for cell morphology analysis (Figure 
7A-C and S8). The PEU hydrogels showed no evidence of toxicity to either ADSCs or FIBs. 
Two-way ANOVA found significant difference between the metabolic activities of ADSCs (p < 
0.0001) and FIBs (p < 0.05) in respect to the test time, while no difference in metabolic activities 
was found between the different PEU hydrogels. Two-sample t-test (p < 0.05) found PEU-1000 
and PEU-1450 hydrogels presented a significant increase in metabolic activity for both cell types 
from day 0 to day 6 or 9, while both cell types showed statistically insignificant metabolic 
activities on the PEU-400 hydrogels. Maximum metabolic activity was achieved for both seeded 
cell types at day 6 without significant differences between day 6 and 9. ADSCs exhibited the 
highest metabolic activity on PEU-1000 hydrogels at day 6 (73% increase compared to day 0 
cell-seeded specimens), while FIBs demonstrated the highest metabolic activity on PEU-1450 
hydrogels at day 6 (51% increase compared to day 0 cell-seeded specimens). The colorimetric 
measurements were visually confirmed by the color change of the blue resazurin dye, with a 
clear change to a purple color (resorufin) for both cell types on all PEU hydrogels from day 0 to 
day 9 (Figure S9). The reduction of blue resazurin to purple resorufin was only seen when living 
cells were present (cell-free control specimens always remained blue). In contrast, the cell-
seeded area on PEU-400 and PEU-1000 hydrogels turned in a distinct pink color, confirming the 
presence of cells on the surfaces and indicating similar metabolic activities between days 6 and 9 
(Figure 7A-C and Figure S8). In contrast, the surfaces of the cell-seeded PEU-1450 hydrogels 
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had less visible color alterations for both cell types after cell seeding (Figure S9), as discussed 
below. 
The confocal microscopic analysis showed elongated morphologies of the ADSCs attached to 
the surface of PEU-400 and PEU-1000 hydrogels and verified highly confluent cell populations 
(Figure 7A-B). FIBs also exhibited elongated morphologies on the PEU-400 and PEU-1000 
hydrogel surfaces, however, the PEU-400 hydrogels facilitated a higher degree of confluence 
compared to the PEU-1000 hydrogels (Figure S8). The surfaces of the PEU-1450 hydrogels 
showed relatively few ADSCs and FIBs (Figure 7C and Figure S8) in line with the colorimetric 
measurements. This may be the result of cell detachment from the PEU hydrogels. It is likely 
that the temperature changes of approximately ±16 °C during the culture period (triggered by 
moving the samples from the incubator to the sterile laminar flow hood for medium changes and 
resazurin incubations) would have resulted in volume alterations of the thermosensitive PEU 
specimens, causing the detachment of cells from the hydrogels.51-54 In these experiments any 
detached cells would then be able to proliferate on the surrounding well plate surfaces. The 
swelling/deswelling rates in response to temperature changes were in the order of PEU-1450 > 
PEU-1000 > PEU-400, and correspondingly the degree of cell detachment was highest in PEU-
1450. 
Overall, the above results showed that the ADSCs and FIBs proliferated on the PEU 
hydrogels, indicating that the PEU hydrogels had no toxic effects on the cells within this test 
period of 9 days. These results are consistent with previous studies on thermoresponsive and 
shape-changing hydrogels where a deliberate change in temperature is then used to release cell 
sheets for subsequent use.51-54 
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3.6 Drug Loading and Release 
These thermoresponsive PEU hydrogels can also be used for drug delivery applications.48 The 
release of the model drug, lidocaine, from PEU hydrogels at 37 °C was assessed using UV-Vis 
spectroscopy. PEUs were loaded with the drug at 5 °C, to enhance the swelling ratio and thus the 
amount of drug loaded into the hydrogels. The release profile of PEUs showed a rapid release 
within the first 4 h, followed by a reduced and sustained drug release in the proceeding time 
(Figure 8). PEU-400, PEU-1000 and PEU-1450 hydrogels obtained maximum drug release of 
15.8% (0.37 mg ml-1), 29.4% (0.70 mg ml-1) and 61.2% (1.62 mg ml-1) after 168 h, respectively. 
The initial rapid release was presumably caused by a higher drug concentration on the outer layer 
of the samples55 and their shrinkage because of the higher test temperature than the drug-loading 
temperature. The subsequent decelerated drug release can be associated with the less permeable 
hydrogel matrix48 and reduced releasable drug content over time. These results demonstrated the 
prospective use of the PEUs in temperature-controlled or sustained drug delivery. With a 
modulated volume phase transition temperature (Figure S10), the PEU hydrogels could also 
potentially feature an temperature dependent on-off drug release.1,3 
 
Figure 8. (A) Cumulative drug release from PEUs versus swelling time at 37 °C in PBS solution 
in a shaker incubator. 
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3.7 Water-temperature Activated Force Generation and Motions 
 
Figure 9. (A) Water temperature activated force generation of submerged and stretched PEU-
1450 strip samples by cyclic alteration of water temperature from ଵܶ = 21 °C to ଶܶ = 37 °C, or 
from (B) ଵܶ = 5 °C to ଶܶ = 37 °C (sharp peaks = replacement of an equal volume of water with 
the pre-determined temperature to achieve the target temperature ଵܶ or ଶܶ). (C) Water 
temperature responsive cantilever composed of a PEU-1450 and a PTFE film strip, transducing 
the water temperature dependent swelling/deswelling response into reversible bending motions. 
Thermoresponsive hydrogels can also be used for actuation and power generation.1,56 PEU-1450 
hydrogels at 40% strain generated temperature-induced contractile forces and stresses (Figure 
9A-B and S1). The cyclic change of water temperature from 21 °C to 37 °C and from 5 °C to 37 
°C generated contractile forces of 16 ± 1 mN and 44 ± 1 mN, and stresses of 1.4 ± 0.03 kPa and 
3.8 ± 0.06 kPa, respectively. Generation of the contractile forces occurred instantly upon 
temperature alteration and was reversible. Their values are affected by the specimen dimensions 
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(e.g. the specific surface area), water temperature difference, environmental conditions and 
swelling/deswelling capability of the PEU hydrogel. Higher contractile forces are achievable by 
altering these parameters, which could then be used to generate ultralow power by attaching a 
piezoelectric element to drive a micro- or nano-device.56 The excellent stimuli-responsiveness of 
the PEU-1450 hydrogel also allowed for the design of water temperature-activated cantilevers 
(Figure 9C and S1), transducing the temperature-stimulus into reversible bending (see Movie 
S1). These characteristics will enable the PEU hydrogels to be used in actuators, sensors, soft 
robotics and fluid control devices.1 
The results presented here demonstrate the successful synthesis of thermoresponsive, 
stretchable, biodegradable and biocompatible PEU hydrogels with tunable physiochemical 
properties for a variety of possible applications. The chemically crosslinked PEU hydrogels have 
structurally stable and highly stretchable characteristics, which may prove useful in mechanically 
dynamic environments for soft tissues.4,5 Conventional thermoresponsive PNIPAm-based 
hydrogels are comparably less ductile, characterized with low elongation at break values of 
~50%,57-60 restraining their scope of potential applications in soft tissue engineering. 
Furthermore, the PEU hydrogels exhibited softer and/or more flexible properties in comparison 
to hydrated PGS-co-PEG block copolymers,24 which presented a <RXQJ¶V PRGXOXV WHQVLOH
strength and elongation at break in the range of 0.013-1.55 MPa, 0.012-0.30 MPa and ~25-200%, 
respectively.24 
The biodegradability and biocompatibility are critical aspects for developing thermosensitive 
PU-based hydrogels for biomedical applications. Further critical examination in vivo is needed to 
assess the potential for PEU hydrogels in soft tissue engineering and/or drug delivery 
applications, along with their prospective use in the development of bioresorbable actuators.60 
Future work can also include fabrication of the PEU hydrogels into different structures to address 
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the needs of different applications. In a proof-of-concept study, the fabrication of the PEU into 
microspheres with a size range of 289 ± 42 µm was achievable by using an oil-in-oil solvent 
evaporation technique (See Supplemental Information for the preparation procedure),61 which 
also presented negative thermo-sensitivity (Figure 10A and Figure S11). Injectable microspheres 
are interesting for localized drug delivery and targeted soft tissue engineering applications.62 The 
proof-of-concept production of large 3D scaffold constructs via freeze-drying (See Supplemental 
Information for the preparation procedure)31,32 was also realizable, producing highly porous and 
interconnected microstructures (Figure 10B and Figure S11) and demonstrating great potential 
for further optimization of the pore size and porosity for soft tissue engineering applications. 
 
Figure 10. SEM images of (A) dry PEU-1000 microspheres, and (B) the microstructure dry 
PEU-1450 scaffold, both fabricated in a proof of concept study. 
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4. CONCLUSIONS 
Thermoresponsive, stretchable, biodegradable and biocompatible PEU hydrogels with varying 
MWt of PEG were synthesized by a facile solvent-based two-step method. The chemical and 
physical characteristics of the covalently crosslinked PEU hydrogels are tunable by changing the 
MWt of the PEG segments. PEU hydrogels were processed into films, with structurally stable 
and highly stretchable mechanical properties in dry and hydrated states. The PEU hydrogels were 
FKDUDFWHUL]HGZLWKDWHQVLOH<RXQJ¶VPRdulus, ultimate tensile strength and elongation at break 
in the range of 0.02-0.20 MPa, 0.05-0.47 MPa and 426-623%, respectively. Compression tests 
showed no fracture and good recoverability after 75% axial strain. The PEU hydrogels 
demonstrated minimal hysteresis loss ratio during cyclic tensile tests, while cyclic compression 
tests showed higher hysteresis loss ratios. The PEU hydrogels were characterized with negative 
thermo-sensitivity, and the equilibrium ratio of swelling depended on the medium temperature 
and PEU composition. The PEU hydrogels demonstrate repetitive and reversible responses to 
changes in medium temperature from 5 oC to 37 oC with the swelling ratio at equilibrium varying 
from 499% to 12%. In vitro degradation tests of PEU hydrogels obtained mass losses of 9-16% 
or 11-21% in 31 days in PBS or lipase solution, respectively. In vitro cell test results provided 
clear evidence that all the PEU hydrogels are biocompatible and suitable for the culture of 
ADSCs and FIBs. 
The PEU hydrogels showed a rapid drug release within the first hour in PBS, followed by a 
sustained drug release rate in the proceeding time and reaching a maximum drug release in the 
range of 16-61% after 168 h. Water temperature activated force generation of submerged and 
stretched PEU strip samples generated contractile forces of 16 ± 1 mN and 44 ± 1 mN and 
stresses of 1.4 ± 0.03 kPa and 3.8 ± 0.06 kPa by cyclic water temperature changes, which 
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occurred instantly upon temperature alteration and was reversible. The proof-of-concept 
fabrication of structures such as PEU microspheres and large 3D scaffolds illustrates versatility 
of the polymers. The thermoresponsivity, high flexibility and stretchability, biodegradability and 
biocompatibility show the potential of the PEU hydrogels to be applied in a variety of 
applications such as soft tissue engineering, temperature-controlled or sustained drug delivery as 
well as thermal actuation. 
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